FDA Device Intelligence
HomePersyst Development Corp › Persyst 12 EEG Review and Analysis Software

Persyst 12 EEG Review and Analysis Software

Persyst Development Corp · Model P12 · UDI-DI 00869732000104

OMAOMBOLT Prescription
1
510(k) clearances
4
Adverse events
3
Recalls
13
Facilities

Description

Persyst 12 EEG Review and Analysis Software is intended for the review, monitoring and analysis of EEG recordings made by electroencephalogram (EEG) devices to aid neurologists in the assessment of EEG. This device is intended to be used by qualified medical practitioners who will exercise professional judgment in using the information.

Recalls

DateFirmReason
2025-05-07Natus Neurology DBA Excel Tech., Ltd. (XLTEK)Electrode placement labels on the Digital Acquisition Box (DAB) were applied backwards. This may ultimately lead to misdiagnosis of seizure location in neonates monitored with this
2023-02-20Moberg Research, Inc.Battery leakage can cause corrosion to the metal enclosure near the electrical interface. Prolonged contact to corrosive materials could cause injury to skin. DOC
2020-03-05Natus Neurology DBA Excel Tech., Ltd. (XLTEK)The OBM system functional test (impedance and noise) was not carried out on the affected items prior to release to the customer. The manufacturer cannot attest to the system functi

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.